Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$13.48 USD
-0.17 (-1.25%)
Updated May 20, 2024 04:00 PM ET
After-Market: $13.47 -0.01 (-0.07%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.48 USD
-0.17 (-1.25%)
Updated May 20, 2024 04:00 PM ET
After-Market: $13.47 -0.01 (-0.07%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth B Momentum B VGM
Zacks News
Inter Parfums (IPAR) Teams Up With G-III Apparel to Boost Growth
by Zacks Equity Research
Inter Parfums (IPAR) enters into a licensing agreement with G-III Apparel to create, develop as well as distribute fragrances and related items.
Coty (COTY) Teams Up With Perfect Corp. to Accelerate Growth
by Zacks Equity Research
Coty (COTY) signs a multi-channel agreement with Perfect Corp. to help customers shop in the most convenient and personalized manner both online and offline.
Zacks Value Investor Highlights: Nu Skin Enterprises, VF Corp, Yamana Gold, Meritor and Vertex Pharmaceuticals
by Zacks Equity Research
Zacks Value Investor Highlights: Nu Skin Enterprises, VF Corp, Yamana Gold, Meritor and Vertex Pharmaceuticals
5 Top Ranked Stocks on Sale Right Now
by Tracey Ryniec
These stocks are disconnected from their earnings outlook as the analysts remain bullish but the Street is bearish.
The Estee Lauder Companies (EL) Gains on Skin Care, Online Strength
by Zacks Equity Research
The Estee Lauder Companies (EL) is implementing new technology and digital experiences to boost growth. Also, the company's Skin Care portfolio is performing well.
Nu Skin Enterprises (NUS) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Helen of Troy (HELE) Up on Solid Leadership Brands & Online Sales
by Zacks Equity Research
Helen of Troy (HELE) is focused on making solid investments in the Leadership Brands. Also, the company is gaining from its consistent online sales.
Ulta Beauty (ULTA) Gains on Growth in Skincare, Digital Wing
by Zacks Equity Research
Ulta Beauty (ULTA) is gaining from growth across beauty categories, especially skincare, Its omni-channel efforts are encouraging.
7 Low Price-to-Sales Stocks to Buy in the Current Market
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, GIII, NUS, MET, PIPR, HIBB, and SMP are promising picks.
Inter Parfums (IPAR) Benefits From Alliances & Product Launches
by Zacks Equity Research
Inter Parfums (IPAR) is focused on product launches that will boost assortment strength. The company concentrates on expanding its business through new licenses and acquisitions.
Coty (COTY) More Than Doubles in a Year: Will Momentum Stay?
by Zacks Equity Research
Coty (COTY) is focused on its core strategies that include achieving solid e-commerce momentum, strengthening presence in China and solidifying its foothold in the prestige category.
Helen of Troy (HELE) Rewards Shareholders, Unveils New Buybacks
by Zacks Equity Research
Helen of Troy (HELE) approves repurchase of shares worth $500 million to return capital not otherwise deployed toward strategic buyouts or core business growth.
Value Stocks & ETFs to Buy Now
by Neena Mishra
Here is what you need to know about value investing...
Why Is Nu Skin (NUS) Down 8.2% Since Last Earnings Report?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Estee Lauder Companies (EL) Up More than 25% YTD: Will it Stay?
by Zacks Equity Research
The Estee Lauder Companies' (EL) Skin Care portfolio is performing well. The company's solid online business is yielding amid pandemic-led hurdles.
Scoop Up These 7 Low Price-to-Sales Stocks Reflecting Strength
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, MT, NUS, MET, PIPR, KBH, and SMP are promising picks.
Coty (COTY) Q4 Loss Wider Than Estimates, Revenues Increase
by Zacks Equity Research
Coty's (COTY) fourth-quarter fiscal 2021 results reflect higher revenues on growth across all regions and channels. However, loss in the quarter was wider than the consensus mark.
Inter Parfums (IPAR) Surges More Than 60% in a Year: Here's Why
by Zacks Equity Research
Inter Parfums (IPAR) has been focused on undertaking product launches to strengthen assortments. The company is expanding its business through strategic partnerships.
7 Low Price-to-Sales Stocks to Replenish Your Portfolio
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like HIBB, BSET, NUS, MET, MT, KBH, and SMP are promising picks.
Nu Skin (NUS) Q2 Earnings Beat Estimates, Sales Grow Y/Y
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2021 earnings and revenues increase year over year on growth in sales leaders. Also, management raises 2021 earnings view.
Nu Skin Enterprises (NUS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 8.49% and 0.21%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin (NUS) Queued for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2021 performance is likely to reflect gains from the company's efforts to strengthen sales leader and expand customer. Also, online strength has been a driver.
Nu Skin Enterprises (NUS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Estee Lauder Companies (EL) Up 61% in a Year: Here's How
by Zacks Equity Research
The Estee Lauder Companies (EL) has a strong online business. The company's Skin Care portfolio is performing well.
Coty's (COTY) Innovation Solid, Launches Touch-Less Fragrance Tester
by Zacks Equity Research
Coty (COTY) will introduce a digitally-enabled touch-less fragrance tester at beauty retailers in the next 12 months. Management expects to improve in-store sales via the launch.